Regulation of PMP22 mRNA by G3BP1 affects cell proliferation in breast cancer cells

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages

  Winslow, Sofia ^a   Leandersson, Karin ^b   Larsson, Christer ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Breast cancer cells; G3BP; Gene expression; PMP22; Proliferation

Indexed keywords

G3BP1 PROTEIN; G3BP2 PROTEIN; MESSENGER RNA; PERIPHERAL MYELIN PROTEIN 22; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; MICROARRAY ANALYSIS; PROTEIN DEPLETION; RNA STABILITY;

ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; CARRIER PROTEINS; CELL PROLIFERATION; CELL SURVIVAL; DACTINOMYCIN; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MCF-7 CELLS; MYELIN PROTEINS; RNA STABILITY; RNA, MESSENGER;

EID: 84889845137     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-156     Document Type: Article

References (37)

1. Schoenberg DR. Mechanisms of endonuclease-mediated mRNA decay. Wiley Interdiscip Rev RNA 2011, 2:582-600. 10.1002/wrna.78, 3347869, 21957046.
2. Wurth L. Versatility of RNA-Binding proteins in cancer. Comp Funct Genomics 2012, 2012:178525. 3359819, 22666083.
3. Kennedy D, French J, Guitard E, Ru K, Tocque B, Mattick J. Characterization of G3BPs: tissue specific expression, chromosomal localisation and rasGAP(120) binding studies. J Cell Biochem 2001, 84:173-187.
4. Parker F, Maurier F, Delumeau I, Duchesne M, Faucher D, Debussche L, Dugue A, Schweighoffer F, Tocque B. A Ras-GTPase-activating protein SH3-domain-binding protein. Mol Cell Biol 1996, 16:2561-2569. 231246, 8649363.
5. Annibaldi A, Dousse A, Martin S, Tazi J, Widmann C. Revisiting G3BP1 as a RasGAP binding protein: sensitization of tumor cells to chemotherapy by the RasGAP 317-326 sequence does not involve G3BP1. PLoS One 2011, 6:e29024. 10.1371/journal.pone.0029024, 3242762, 22205990.
6. Atlas R, Behar L, Elliott E, Ginzburg I. The insulin-like growth factor mRNA binding-protein IMP-1 and the Ras-regulatory protein G3BP associate with tau mRNA and HuD protein in differentiated P19 neuronal cells. J Neurochem 2004, 89:613-626. 10.1111/j.1471-4159.2004.02371.x, 15086518.
7. Gallouzi IE, Parker F, Chebli K, Maurier F, Labourier E, Barlat I, Capony JP, Tocque B, Tazi J. A novel phosphorylation-dependent RNase activity of GAP-SH3 binding protein: a potential link between signal transduction and RNA stability. Mol Cell Biol 1998, 18:3956-3965. 108980, 9632780.
8. Taniuchi K, Nishimori I, Hollingsworth MA. The N-terminal domain of G3BP enhances cell motility and invasion by posttranscriptional regulation of BART. Mol Cancer Res 2011, 9:856-866. 10.1158/1541-7786.MCR-10-0574, 21665939.
9. Bikkavilli RK, Malbon CC. Arginine methylation of G3BP1 in response to Wnt3a regulates beta-catenin mRNA. J Cell Sci 2011, 124:2310-2320. 10.1242/jcs.084046, 3113675, 21652632.
10. Ortega AD, Willers IM, Sala S, Cuezva JM. Human G3BP1 interacts with beta-F1-ATPase mRNA and inhibits its translation. J Cell Sci 2010, 123:2685-2696. 10.1242/jcs.065920, 20663914.
11. Zekri L, Chebli K, Tourriere H, Nielsen FC, Hansen TV, Rami A, Tazi J. Control of fetal growth and neonatal survival by the RasGAP-associated endoribonuclease G3BP. Mol Cell Biol 2005, 25:8703-8716. 10.1128/MCB.25.19.8703-8716.2005, 1265751, 16166649.
12. Tourriere H, Gallouzi IE, Chebli K, Capony JP, Mouaikel J, van der Geer P, Tazi J. RasGAP-associated endoribonuclease G3Bp: selective RNA degradation and phosphorylation-dependent localization. Mol Cell Biol 2001, 21:7747-7760. 10.1128/MCB.21.22.7747-7760.2001, 99945, 11604510.
13. Guitard E, Parker F, Millon R, Abecassis J, Tocque B. G3BP is overexpressed in human tumors and promotes S phase entry. Cancer Lett 2001, 162:213-221. 10.1016/S0304-3835(00)00638-8, 11146228.
14. Kociok N, Esser P, Unfried K, Parker F, Schraermeyer U, Grisanti S, Toque B, Heimann K. Upregulation of the RAS-GTPase activating protein (GAP)-binding protein (G3BP) in proliferating RPE cells. J Cell Biochem 1999, 74:194-201. 10.1002/(SICI)1097-4644(19990801)74:2<194::AID-JCB5>3.0.CO;2-M, 10404389.
15. Barnes CJ, Li F, Mandal M, Yang Z, Sahin AA, Kumar R. Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors. Cancer Res 2002, 62:1251-1255.
16. French J, Stirling R, Walsh M, Kennedy HD. The expression of Ras-GTPase activating protein SH3 domain-binding proteins, G3BPs, in human breast cancers. Histochem J 2002, 34:223-231. 10.1023/A:1021737413055, 12587999.
17. Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell 1988, 54:787-793. 10.1016/S0092-8674(88)91065-3, 3409319.
18. Manfioletti G, Ruaro ME, Del Sal G, Philipson L, Schneider C. A growth arrest-specific (gas) gene codes for a membrane protein. Mol Cell Biol 1990, 10:2924-2930. 360655, 1692961.
19. Zhang H, Zhang S, He H, Zhao W, Chen J, Shao RG. GAP161 targets and downregulates G3BP to suppress cell growth and potentiate cisplaitin-mediated cytotoxicity to colon carcinoma HCT116 cells. Cancer Sci 2012, 103:1848-1856. 10.1111/j.1349-7006.2012.02361.x, 22703643.
20. Irvine K, Stirling R, Hume D, Kennedy D. Rasputin, more promiscuous than ever: a review of G3BP. Int J Dev Biol 2004, 48:1065-1077. 10.1387/ijdb.041893ki, 15602692.
21. Tourriere H, Chebli K, Zekri L, Courselaud B, Blanchard JM, Bertrand E, Tazi J. The RasGAP-associated endoribonuclease G3BP assembles stress granules. J Cell Biol 2003, 160:823-831. 10.1083/jcb.200212128, 2173781, 12642610.
22. Matsuki H, Takahashi M, Higuchi M, Makokha GN, Oie M, Fujii M. Both G3BP1 and G3BP2 contribute to stress granule formation. Genes Cells 2013, 18:135-146. 10.1111/gtc.12023, 23279204.
23. Kobayashi T, Winslow S, Sunesson L, Hellman U, Larsson C. PKCalpha binds G3BP2 and regulates stress granule formation following cellular stress. PLoS One 2012, 7:e35820. 10.1371/journal.pone.0035820, 3335008, 22536444.
24. Snipes GJ, Suter U, Welcher AA, Shooter EM. Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J Cell Biol 1992, 117:225-238. 10.1083/jcb.117.1.225, 2289391, 1556154.
25. Spreyer P, Kuhn G, Hanemann CO, Gillen C, Schaal H, Kuhn R, Lemke G, Muller HW. Axon-regulated expression of a Schwann cell transcript that is homologous to a 'growth arrest-specific' gene. EMBO J 1991, 10:3661-3668. 453098, 1935894.
26. Muller HW. Tetraspan myelin protein PMP22 and demyelinating peripheral neuropathies: new facts and hypotheses. Glia 2000, 29:182-185. 10.1002/(SICI)1098-1136(20000115)29:2<182::AID-GLIA12>3.0.CO;2-K, 10625337.
27. Naef R, Suter U. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Neurobiol Dis 1999, 6:1-14. 10.1006/nbdi.1998.0227, 10078969.
28. Suter U, Nave KA. Transgenic mouse models of CMT1A and HNPP. Ann N Y Acad Sci 1999, 883:247-253. 10.1111/j.1749-6632.1999.tb08586.x, 10586249.
29. Huhne K, Park O, Liehr T, Rautenstrauss B. Expression analysis of the PMP22 gene in glioma and osteogenic sarcoma cell lines. J Neurosci Res 1999, 58:624-631. 10.1002/(SICI)1097-4547(19991201)58:5<624::AID-JNR3>3.0.CO;2-N, 10561690.
30. Li J, Kleeff J, Esposito I, Kayed H, Felix K, Giese T, Buchler MW, Friess H. Expression analysis of PMP22/Gas3 in premalignant and malignant pancreatic lesions. J Histochem Cytochem 2005, 53:885-893. 10.1369/jhc.4A6546.2005, 15995147.
31. Tong D, Heinze G, Pils D, Wolf A, Singer CF, Concin N, Hofstetter G, Schiebel I, Rudas M, Zeillinger R. Gene expression of PMP22 is an independent prognostic factor for disease-free and overall survival in breast cancer patients. BMC Cancer 2010, 10:682. 10.1186/1471-2407-10-682, 3018461, 21159173.
32. Taylor V, Welcher AA, Program AE, Suter U. Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family. J Biol Chem 1995, 270:28824-28833. 10.1074/jbc.270.48.28824, 7499407.
33. van Dartel M, Hulsebos TJ. Characterization of PMP22 expression in osteosarcoma. Cancer Genet Cytogenet 2004, 152:113-118. 10.1016/j.cancergencyto.2003.11.003, 15262428.
34. Roux KJ, Amici SA, Fletcher BS, Notterpek L. Modulation of epithelial morphology, monolayer permeability, and cell migration by growth arrest specific 3/peripheral myelin protein 22. Mol Biol Cell 2005, 16:1142-1151. 10.1091/mbc.E04-07-0551, 551480, 15635102.
35. Zoidl G, Blass-Kampmann S, D'Urso D, Schmalenbach C, Muller HW. Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J 1995, 14:1122-1128. 398189, 7720703.
36. Verrier JD, Lau P, Hudson L, Murashov AK, Renne R, Notterpek L. Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a. Glia 2009, 57:1265-1279. 10.1002/glia.20846, 2713384, 19170179.
37. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008, 24:1547-1548. 10.1093/bioinformatics/btn224, 18467348.